Hepatic Mitochondrial Dysfunction and Risk of Liver Disease in an Ovine Model of "PCOS Males".
Hepatic Mitochondrial Dysfunction and Risk of Liver Disease in an Ovine Model of "PCOS Males".
复制标题
DOI:
10.3390/biomedicines10061291
复制
发表时间:
2022-05-31
期刊:
影响因子:
4.7
通讯作者:
中科院分区:
文献类型:
--
作者:
First-degree male relatives of polycystic ovary syndrome (PCOS) sufferers can develop metabolic abnormalities evidenced by elevated circulating cholesterol and triglycerides, suggestive of a male PCOS equivalent. Similarly, male sheep overexposed to excess androgens in fetal life develop dyslipidaemia in adolescence. Dyslipidaemia, altered lipid metabolism, and dysfunctional hepatic mitochondria are associated with the development of non-alcoholic liver disease (NAFLD). We therefore dissected hepatic mitochondrial function and lipid metabolism in adolescent prenatally androgenized (PA) males from an ovine model of PCOS. Testosterone was directly administered to male ovine fetuses to create prenatal androgenic overexposure. Liver RNA sequencing and proteomics occurred at 6 months of age. Hepatic lipids, glycogen, ATP, reactive oxygen species (ROS), DNA damage, and collagen were assessed. Adolescent PA males had an increased accumulation of hepatic cholesterol and glycogen, together with perturbed glucose and fatty acid metabolism, mitochondrial dysfunction, with altered mitochondrial transport, decreased oxidative phosphorylation and ATP synthesis, and impaired mitophagy. Mitochondrial dysfunction in PA males was associated with increased hepatic ROS level and signs of early liver fibrosis, with clinical relevance to NAFLD progression. We conclude that excess in utero androgen exposure in male fetuses leads to a PCOS-like metabolic phenotype with dysregulated mitochondrial function and likely lifelong health sequelae.
登录
查看更多内容
DOI:
10.1111/liv.14773
发表时间:
2021-05
期刊:
Liver international : official journal of the International Association for the Study of the Liver
影响因子:
--
作者:
Allende DS;Gawrieh S;Cummings OW;Belt P;Wilson L;Van Natta M;Behling CA;Carpenter D;Gill RM;Kleiner DE;Yeh MM;Chalasani N;Guy CD;NASH Clinical Research Network
通讯作者:
NASH Clinical Research Network
影响因子:
29.4
作者:
Cotter, Thomas G.;Rinella, Mary
通讯作者:
Rinella, Mary
影响因子:
7.5
作者:
Dabravolski, Siarhei A.;Bezsonov, Evgeny E.;Orekhov, Alexander N.
通讯作者:
Orekhov, Alexander N.
影响因子:
6
作者:
Asimakopoulou, Anastasia;Engel, Kathrin M.;Weiskirchen, Ralf
通讯作者:
Weiskirchen, Ralf
DOI:
10.1017/s2040174417001118
发表时间:
2018-06
影响因子:
1.7
作者:
Barrett ES;Hoeger KM;Sathyanarayana S;Abbott DH;Redmon JB;Nguyen RHN;Swan SH
通讯作者:
Swan SH